Synbio Tech Inc.

NT$44.80As of Sun 8 Nov 2026, 12:00 UTC
TPEx:1295Healthcare
Country Taiwan
PE (Fwd) •••
TSR 3Y CAGR (14.53%)
Div yield 6.70%
ROE 11.21%
Biotechnology
Beta (5Y) 0.49
PE TTM 10.90
TSR TTM (56.10%)
Mkt cap NT$1.544B
ROIC 5.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$50
11.52%
241.67%
Hold 9|11|12|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.42
0.45
0.43
0.47
1.64%
9.32%
(1.88%)
8.81%
RevenueNT$M
132.1
135.9
136.3
143.5
4.64%
6.83%
4.16%
11.89%
Peers (US$46.65M)
Cap (US$)
PE
43.25M
20.79x
46.60M
—
Capital
TTM
5Y
10Y
Leveragex
8.407
(0.938)
(0.872)
EBIT/Intx
0.860
0.112
0.112
Own earn%
(459.12)
(6.98)
(4.11)
Sh yield%
17.27
5.16
5.90
Owners
Insiders/Inst%
5.57
66.70
Short interest%
3.83
SBC / revenue%
3.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
0–3
$1 testx
−0.2
Incr. ROIC%
4